Factory Direct XCE Tirzepatide LY3298176 Pharmaceutical Grade Peptide

XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This innovative peptide demonstrates significantly enhanced efficacy in both glucose regulation and weight management compared to single-receptor agonists.

The XCE Tirzepatide compound features unique dual agonist properties with greater affinity for GIP receptors than GLP-1 receptors. This distinctive mechanism has been shown in research to produce superior reductions in hyperglycemia when compared to selective GLP-1 receptor agonists. The compound effectively mimics the actions of natural GIP at the GIP receptor while maintaining potent GLP-1 activity.

Our XCE Tirzepatide is produced under strict pharmaceutical-grade conditions, ensuring high purity (>98%) and consistent batch-to-batch quality. The white powder formulation offers excellent stability when stored properly, making it ideal for research applications.

Key advantages of XCE Tirzepatide include enhanced β-cell responses, reduced glucagon secretion from α-cells, decreased hepatic glucose output, and effects on appetite regulation and gastric emptying. These combined actions help reduce β-cell load while improving metabolic parameters.

For research purposes only. Not for human consumption. This product is intended solely for laboratory research by qualified professionals.